Andrew J. Geall

4.2k total citations · 1 hit paper
34 papers, 2.7k citations indexed

About

Andrew J. Geall is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Andrew J. Geall has authored 34 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Andrew J. Geall's work include RNA Interference and Gene Delivery (20 papers), Immunotherapy and Immune Responses (10 papers) and Virus-based gene therapy research (7 papers). Andrew J. Geall is often cited by papers focused on RNA Interference and Gene Delivery (20 papers), Immunotherapy and Immune Responses (10 papers) and Virus-based gene therapy research (7 papers). Andrew J. Geall collaborates with scholars based in United States, United Kingdom and Italy. Andrew J. Geall's co-authors include Jeffrey B. Ulmer, Christian W. Mandl, Peter W. Mason, Ian S. Blagbrough, Anna K. Blakney, Luis A. Brito, Shell Ip, Gillis R. Otten, Cinzia Giovani and Philip R. Dormitzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Andrew J. Geall

32 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonviral delivery of self-amplifying RNA vaccines

2012 525 citations Andrew J. Geall, Gillis R. Otten et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew J. Geall United States	26	1.9k	878	807	414	292	34	2.7k
Luis A. Brito United States	21	2.3k 1.2×	1.3k 1.5×	1.2k 1.5×	416 1.0×	505 1.7×	24	3.6k
Kimberly J. Hassett United States	12	1.5k 0.8×	742 0.8×	827 1.0×	247 0.6×	306 1.0×	14	2.2k
Alan Cochrane Canada	34	2.4k 1.3×	565 0.6×	932 1.2×	355 0.9×	300 1.0×	79	3.5k
Min Tang China	15	874 0.5×	845 1.0×	571 0.7×	192 0.5×	512 1.8×	36	2.3k
Fei Guo China	32	1.8k 0.9×	1.3k 1.4×	1.6k 2.0×	278 0.7×	868 3.0×	100	4.1k
Debra M. Eckert United States	23	1.8k 0.9×	586 0.7×	1.0k 1.3×	191 0.5×	663 2.3×	40	3.4k
Martijn A. Langereis Netherlands	30	1.2k 0.7×	679 0.8×	904 1.1×	217 0.5×	375 1.3×	40	2.5k
Qiaozhen Ye United States	22	1.3k 0.7×	399 0.5×	648 0.8×	185 0.4×	527 1.8×	34	2.2k
Céline Lacroix France	23	1.1k 0.6×	637 0.7×	647 0.8×	328 0.8×	420 1.4×	37	2.3k
Oleksandr Kalyuzhniy United States	17	1.3k 0.7×	837 1.0×	508 0.6×	505 1.2×	405 1.4×	26	2.4k

Countries citing papers authored by Andrew J. Geall

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Geall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Geall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Geall more than expected).

Fields of papers citing papers by Andrew J. Geall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Geall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Geall. The network helps show where Andrew J. Geall may publish in the future.

Co-authorship network of co-authors of Andrew J. Geall

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Geall. A scholar is included among the top collaborators of Andrew J. Geall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Geall. Andrew J. Geall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyake‐Stoner, Shigeki J., Brandon Essink, Jessica L. Sparks, et al.. (2025). Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trial. Communications Medicine. 5(1). 392–392.

Varley, Andrew, Shigeki J. Miyake‐Stoner, Parinaz Aliahmad, et al.. (2025). Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA Modalities. Advanced Science. 12(38). e08907–e08907.

Malecová, Barbora, Rob S. Burke, Michael A. Cochran, et al.. (2023). Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs). Nucleic Acids Research. 51(12). 5901–5910. 75 indexed citations

Geall, Andrew J., Zoltán Kis, & Jeffrey B. Ulmer. (2022). Vaccines on demand, part II: future reality. Expert Opinion on Drug Discovery. 18(2). 119–127. 7 indexed citations

Aliahmad, Parinaz, Shigeki J. Miyake‐Stoner, Andrew J. Geall, & Nathaniel Wang. (2022). Next generation self-replicating RNA vectors for vaccines and immunotherapies. Cancer Gene Therapy. 30(6). 785–793. 30 indexed citations

Blakney, Anna K., Paul F. McKay, Kai Hu, et al.. (2021). Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. Journal of Controlled Release. 338. 201–210. 89 indexed citations

Blakney, Anna K., Shell Ip, & Andrew J. Geall. (2021). An Update on Self-Amplifying mRNA Vaccine Development. Vaccines. 9(2). 97–97. 176 indexed citations

Samsa, Marcelo M., Lesley C. Dupuy, Clayton W. Beard, et al.. (2019). Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice. Molecular Therapy. 27(4). 850–865. 51 indexed citations

Pulichino, Anne-Marie, Thomas Carsillo, Alicia L. Carlson, et al.. (2017). Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design. The Journal of Immunology. 198(10). 4012–4024. 158 indexed citations

10.

Maruggi, Giulietta, Emiliano Chiarot, Cinzia Giovani, et al.. (2016). Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens. Vaccine. 35(2). 361–368. 111 indexed citations

11.

Bell, Christie, Dong Yü, Christina D. Smolke, et al.. (2015). Control of alphavirus-based gene expression using engineered riboswitches. Virology. 483. 302–311. 37 indexed citations

12.

Brazzoli, Michela, Diletta Magini, Alessandra Bonci, et al.. (2015). Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin. Journal of Virology. 90(1). 332–344. 126 indexed citations

13.

Lazzaro, Sandra, Cinzia Giovani, Diletta Magini, et al.. (2015). CD8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes. Immunology. 146(2). 312–326. 66 indexed citations

14.

Deering, Raquel P., Sushma Kommareddy, Jeffrey B. Ulmer, Luis A. Brito, & Andrew J. Geall. (2014). Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opinion on Drug Delivery. 11(6). 885–899. 132 indexed citations

15.

Brito, Luis A., Sushma Kommareddy, Domenico Maione, et al.. (2014). Self-Amplifying mRNA Vaccines. Advances in genetics. 89. 179–233. 142 indexed citations

16.

Geall, Andrew J., Christian W. Mandl, & Jeffrey B. Ulmer. (2013). RNA: The new revolution in nucleic acid vaccines. Seminars in Immunology. 25(2). 152–159. 136 indexed citations

17.

Ulmer, Jeffrey B., Peter W. Mason, Andrew J. Geall, & Christian W. Mandl. (2012). RNA-based vaccines. Vaccine. 30(30). 4414–4418. 138 indexed citations

18.

Blagbrough, Ian S., Abdelkader A. Metwally, & Andrew J. Geall. (2011). Measurement of Polyamine pK a Values. Methods in molecular biology. 720. 493–503. 30 indexed citations

19.

Manthorpe, Marston, Peter Hobart, Gary Hermanson, et al.. (2005). Plasmid Vaccines and Therapeutics: From Design to Applications. Advances in biochemical engineering, biotechnology. 99. 41–92. 16 indexed citations

20.

Geall, Andrew J., Michael A. W. Eaton, Terry Baker, Catherine Catterall, & Ian S. Blagbrough. (1999). The regiochemical distribution of positive charges along cholesterol polyamine carbamates plays significant roles in modulating DNA binding affinity and lipofection. FEBS Letters. 459(3). 337–342. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact